Ahead of the company’s second-quarter earnings call Aug. 6, Oscar Health is slashing its full-year guidance by about half a ...

Fintel reports that on July 25, 2025, Baird downgraded their outlook for Oscar Health (NYSE:OSCR) from Outperform to Neutral.

In the latest trading session, Oscar Health, Inc. (OSCR) closed at $14.45, marking a +1.76% move from the previous day. This change outpaced the S&P 500's 0.4% gain on the day. Meanwhile, the Dow ...

Oscar Health, Inc. ("Oscar" or the "Company") (NYSE: OSCR), a leading healthcare technology company, announced today certain ...

Oscar's strong revenue growth, improving profitability, and efficient SG&A management support my positive outlook. Read why ...

Oscar Health (NYSE:OSCR) stock fell 3.5% after the healthcare technology company revised its 2025 financial guidance following a review of second quarter Marketplace data that revealed ...

The health insurance agency said Tuesday it now expects a medical loss ratio of 86% to 87% for the full year, with total revenue now seen at $12 billion to $12.2 billion and a loss from operations of ...

Investing.com -- Oscar Health has increased its full-year revenue forecast to between $12 billion and $12.2 billion, up from its previous guidance of $11.20 billion to $11.30 billion. This new outlook ...

Is OSCR in Good Health? Oscar Health (NYSE:OSCR) is a technology-driven health insurance company specializing in individual, ...

Oscar Health (OSCR 1.54%) has fallen over 70% since it went public this March. But the stock is deeply misunderstood. Oscar may now be one of the best long-term U.S. technology investments ...

Introduction. Oscar Health (NYSE:OSCR) is an insurance-tech company founded in 2012 after the passage of the Affordable Care Act.It aims to solve the problems created by the complexities and ...

Oscar Health CEO Mario Schlosser speaks at the 2017 Best in the Business Awards at Trianon Ballroom ... More at The New York Hilton Midtown on November 9, 2017 in New York City.